Today's Edition
Friday, August 7, 2026
The day's most important micro-cap signals — earnings, financings, halts, insider buys, and market movement — compressed for decision-makers.
The day's most important micro-cap signals — earnings, financings, halts, insider buys, and market movement — compressed for decision-makers.
SIGNAL CHECK ·Latigo Biotherapeutics (LTGO) — with $321M raised pre-IPO, Phase 2b data published in NEJM, FDA Fast Track designation, and a 52% opioid-free rate — goes public at ~$1B valuation to challenge Vertex's Journavx in the multibillion-dollar non-opioid pain market.
Get this briefing in your inbox daily.
Subscribe →